Neurocrine Biosciences Inc NBIX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/21/21 EDT
104.40quote price arrow up+0.40 (+0.38%)
Volume
10,016
Close
104.00quote price arrow up+0.63 (+0.61%)
Volume
654,803
52 week range
84.77 - 120.27
Loading...
  • Open103.92
  • Day High104.41
  • Day Low103.16
  • Prev Close104.00
  • 52 Week High120.27
  • 52 Week High Date01/25/21
  • 52 Week Low84.77
  • 52 Week Low Date08/12/21

Key Stats

  • Market Cap9.844B
  • Shares Out94.65M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change8.5

KEY STATS

  • Open103.92
  • Day High104.41
  • Day Low103.16
  • Prev Close104.00
  • 52 Week High120.27
  • 52 Week High Date01/25/21
  • 52 Week Low84.77
  • 52 Week Low Date08/12/21
  • Market Cap9.844B
  • Shares Out94.65M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change8.5

RATIOS/PROFITABILITY

  • EPS (TTM)3.72
  • P/E (TTM)27.94
  • Fwd P/E (NTM)37.34
  • EBITDA (TTM)254.80M
  • ROE (TTM)34.56%
  • Revenue (TTM)1.032B
  • Gross Margin (TTM)98.88%
  • Net Margin (TTM)35.34%
  • Debt To Equity (MRQ)25.51%

EVENTS

  • Earnings Date11/01/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Neurocrine Biosciences Inc

There is no recent news for this security.

Profile

MORE
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering, developing, and delivering treatments for people with neurological, endocrine and psychiatric disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis, uterine fibroids, and clinical programs in multiple therapeutic areas. The Company's product pipeline includes INGREZZA (valbenazine), which provides a...
William Rastetter Ph.D.
Non-Executive Chairman
Kevin Gorman Ph.D.
Chief Executive Officer
Matthew Abernethy CPA
Chief Financial Officer
Address
12780 El Camino Real
San Diego, CA
92130-2042
United States

Top Peers

SYMBOLLASTCHG%CHG
MEDP
Medpace Holdings Inc
186.03-2.02-1.07%
NVAX
Novavax Inc
138.79+1.93+1.41%
CRSP
CRISPR Therapeutics AG
97.06-1.31-1.33%
EXEL
Exelixis Inc
21.33-0.31-1.43%
NTRA
Natera Inc
112.32-0.11-0.10%